688202 美迪西
交易中 05-28 14:29:38
资讯
新帖
简况
美迪西：5月19日接受机构调研，国海证券、建信基金参与
证券之星 · 05-25 15:28
美迪西：5月19日接受机构调研，国海证券、建信基金参与
股市必读：5月22日美迪西发布公告，股东减持57万股
证券之星 · 05-25
股市必读：5月22日美迪西发布公告，股东减持57万股
每周股票复盘：美迪西（688202）股东林长青减持57.0万股
证券之星 · 05-24
每周股票复盘：美迪西（688202）股东林长青减持57.0万股
5月22日美迪西发布公告，股东减持57万股
证券之星 · 05-22
5月22日美迪西发布公告，股东减持57万股
5月19日美迪西跌7.10%，广发医疗保健股票A基金重仓该股
证券之星 · 05-19
5月19日美迪西跌7.10%，广发医疗保健股票A基金重仓该股
每周股票复盘：美迪西（688202）部分募投项目延期至2027年
证券之星 · 05-17
每周股票复盘：美迪西（688202）部分募投项目延期至2027年
美迪西（688202）披露2025年年度股东会决议公告，5月14日股价下跌1.42%
证券之星 · 05-14
美迪西（688202）披露2025年年度股东会决议公告，5月14日股价下跌1.42%
美迪西（688202）披露保荐总结报告书，5月13日股价上涨2.17%
证券之星 · 05-13
美迪西（688202）披露保荐总结报告书，5月13日股价上涨2.17%
5月11日美迪西涨6.07%，广发医疗保健股票A基金重仓该股
证券之星 · 05-11
5月11日美迪西涨6.07%，广发医疗保健股票A基金重仓该股
每周股票复盘：美迪西（688202）将召开2025年度股东会及业绩说明会
证券之星 · 05-10
每周股票复盘：美迪西（688202）将召开2025年度股东会及业绩说明会
美迪西（688202）披露2025年年度股东会会议资料，5月8日股价下跌0.31%
证券之星 · 05-08
美迪西（688202）披露2025年年度股东会会议资料，5月8日股价下跌0.31%
股市必读：美迪西一季报 - 第一季度单季净利润同比增长207.35%
证券之星 · 05-06
股市必读：美迪西一季报 - 第一季度单季净利润同比增长207.35%
每周股票复盘：美迪西（688202）Q1净利同比增207.35%
证券之星 · 05-02
每周股票复盘：美迪西（688202）Q1净利同比增207.35%
美迪西连亏三年：毛利率修复缓慢，诉讼与资产减值阴影未散
新浪证券 · 04-30
美迪西连亏三年：毛利率修复缓慢，诉讼与资产减值阴影未散
图解美迪西一季报：第一季度单季净利润同比增长207.35%
证券之星 · 04-30
图解美迪西一季报：第一季度单季净利润同比增长207.35%
每周股票复盘：美迪西（688202）2025年营收增12.08%，股东户数降2.96%
证券之星 · 04-26
每周股票复盘：美迪西（688202）2025年营收增12.08%，股东户数降2.96%
美迪西(688202)3月31日股东户数1.35万户，较上期减少2.96%
证券之星 · 04-23
美迪西(688202)3月31日股东户数1.35万户，较上期减少2.96%
美迪西2025年营收11.63亿元增12.08%，境外收入占比升至47.15%、经营性现金流转正
蓝鲸财经 · 04-23
美迪西2025年营收11.63亿元增12.08%，境外收入占比升至47.15%、经营性现金流转正
3月23日美迪西跌5.85%，信澳优享生活混合A基金重仓该股
证券之星 · 03-23
3月23日美迪西跌5.85%，信澳优享生活混合A基金重仓该股
【机构调研记录】长盛基金调研美迪西、万马科技
证券之星 · 03-20
【机构调研记录】长盛基金调研美迪西、万马科技
加载更多
公司概况
公司名称：
上海美迪西生物医药股份有限公司
所属行业：
研究和试验发展
上市日期：
2019-11-05
主营业务：
上海美迪西生物医药股份有限公司的主营业务是通过研发技术平台向药企及科研单位提供药物发现与药学研究、临床前研究的医药研发服务。公司的主要产品是药物发现、药学研究、临床前研究。2025年6月20日，公司凭借在生物医药领域的全球化研发布局，成功入选浦东新区首批“出海先锋企业”，全球化发展成果获得权威认可。
发行价格：
41.50
{"stockData":{"symbol":"688202","market":"SH","secType":"STK","nameCN":"美迪西","latestPrice":61.21,"timestamp":1779949778000,"preClose":60.78,"halted":0,"volume":3088748,"delay":0,"changeRate":0.0071,"floatShares":134000000,"shares":134000000,"eps":-1.0247,"marketStatus":"交易中","change":0.43,"latestTime":"05-28 14:29:38","open":60.88,"high":63.55,"low":60.25,"amount":191000000,"amplitude":0.0543,"askPrice":61.29,"askSize":4,"bidPrice":61.25,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-1.0247,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1779951600000},"marketStatusCode":2,"adr":0,"adjPreClose":60.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":66.86,"lowLimit":54.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":134352184,"isCdr":false,"pbRate":4.17,"roa":"--","roe":"0.8%","epsLYR":-1.27,"committee":-0.660131,"marketValue":8224000000,"turnoverRate":0.023,"status":0,"floatMarketCap":8224000000},"requestUrl":"/m/hq/s/688202","defaultTab":"news","newsList":[{"id":"2638339525","title":"美迪西：5月19日接受机构调研，国海证券、建信基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2638339525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638339525?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:28","pubTimestamp":1779694113,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年5月22日美迪西发布公告称公司于2026年5月19日接受机构调研，国海证券、建信基金参与。美迪西2026年一季报显示，一季度公司主营收入3.65亿元，同比上升36.52%；归母净利润1561.54万元，同比上升207.35%；扣非净利润1087.63万元，同比上升156.11%；负债率29.2%，投资收益141.09万元，财务费用542.64万元，毛利率26.05%。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500015446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0216","BK0183","688202","BK0188","BK0174","BK0276","000750"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638905304","title":"股市必读：5月22日美迪西发布公告，股东减持57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638905304","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638905304?lang=zh_cn&edition=full","pubTime":"2026-05-25 02:06","pubTimestamp":1779645976,"startTime":"0","endTime":"0","summary":"股本股东变化股东增减持5月22日美迪西发布公告《美迪西:股东减持计划时间届满暨减持股份结果公告》，其股东林长青于2026年2月24日至2026年5月22日间合计减持57.0万股，占公司目前总股本的0.4243%，变动期间该股股价下跌3.31%，截止5月22日收盘报64.25元。2026年1月26日其披露减持计划，拟减持不超过800,000股，即不超过公司总股本的0.60%。截至2026年5月22日，林长青通过集中竞价方式累计减持公司股份570,000股，占公司总股本的0.42%，减持计划时间届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373422","title":"每周股票复盘：美迪西（688202）股东林长青减持57.0万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373422","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637373422?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:49","pubTimestamp":1779562149,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，美迪西报收于64.25元，较上周的65.97元下跌2.61%。本周关注点股本股东变化：股东林长青减持57.0万股，占总股本0.4243%公司公告汇总：SHELLY CHEN TAN当选职工代表董事，系实控人之女股本股东变化股东增减持5月22日美迪西发布公告，股东林长青于2026年2月24日至2026年5月22日期间合计减持57.0万股，占公司目前总股本的0.4243%。截至2026年5月22日，林长青通过集中竞价方式累计减持公司股份570,000股，占公司总股本的0.42%，减持计划时间届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311842","title":"5月22日美迪西发布公告，股东减持57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637311842?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:01","pubTimestamp":1779451278,"startTime":"0","endTime":"0","summary":"证券之星消息，5月22日美迪西发布公告《美迪西:股东减持计划时间届满暨减持股份结果公告》，其股东林长青于2026年2月24日至2026年5月22日间合计减持57.0万股，占公司目前总股本的0.4243%，变动期间该股股价下跌3.31%，截止5月22日收盘报64.25元。股东增减持详情见下表：根据美迪西2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200039979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636362978","title":"5月19日美迪西跌7.10%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636362978","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636362978?lang=zh_cn&edition=full","pubTime":"2026-05-19 16:28","pubTimestamp":1779179322,"startTime":"0","endTime":"0","summary":"证券之星消息，5月19日美迪西跌7.10%，收盘报63.99元，换手率6.82%，成交量9.16万手，成交额6.03亿元。重仓美迪西的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级1家，增持评级2家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为39.07亿元，最新净值1.7465，较上一交易日下跌1.37%，近一年下跌0.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900028955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636640990","title":"每周股票复盘：美迪西（688202）部分募投项目延期至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=2636640990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636640990?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:55","pubTimestamp":1778961309,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，美迪西报收于65.97元，较上周的61.26元上涨7.69%。本周关注点来自公司公告汇总：美迪西部分募投项目延期至2027年1月，另有项目终止并调整募集资金用途。来自公司公告汇总：美迪西2025年年度股东会审议通过利润分配预案、续聘审计机构等多项议案。公司公告汇总广发证券作为上海美迪西生物医药股份有限公司向特定对象发行股票的保荐机构，持续督导期至2025年12月31日届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635746516","title":"美迪西（688202）披露2025年年度股东会决议公告，5月14日股价下跌1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635746516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635746516?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:42","pubTimestamp":1778769737,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，美迪西报收于65.95元，较前一交易日下跌1.42%，最新总市值为88.61亿元。该股当日开盘66.91元，最高67.59元，最低64.6元，成交额达2.91亿元，换手率为3.28%。近日，上海美迪西生物医药股份有限公司发布《2025年年度股东会决议公告》。北京市安理律师事务所对本次会议进行了见证并出具法律意见书，确认会议决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635299733","title":"美迪西（688202）披露保荐总结报告书，5月13日股价上涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635299733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635299733?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:26","pubTimestamp":1778682381,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，美迪西报收于66.9元，较前一交易日上涨2.17%，最新总市值为89.88亿元。近日，广发证券股份有限公司发布《关于上海美迪西生物医药股份有限公司向特定对象发行股票之保荐总结报告书》。公告显示，广发证券作为美迪西向特定对象发行股票的保荐机构，持续督导期至2025年12月31日届满。截至2025年末，募集资金尚未使用完毕，保荐机构将继续履行督导义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634096434","title":"5月11日美迪西涨6.07%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634096434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634096434?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:29","pubTimestamp":1778488196,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日美迪西涨6.07%，收盘报64.98元，换手率5.08%，成交量6.82万手，成交额4.31亿元。重仓美迪西的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，增持评级2家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为39.07亿元，最新净值1.8162，较上一交易日下跌1.87%，近一年上涨3.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100021896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634122114","title":"每周股票复盘：美迪西（688202）将召开2025年度股东会及业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2634122114","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634122114?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:52","pubTimestamp":1778356330,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，美迪西报收于61.26元，较上周的63.26元下跌3.16%。本周，美迪西5月6日盘中最高价报64.51元。本周关注点公司公告汇总：美迪西将于2026年5月14日召开2025年年度股东会，审议财务决算、利润分配等多项议案。公司公告汇总：美迪西将于2026年5月14日举行2025年度暨2026年第一季度业绩说明会，董事长及CEO将出席。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633543780","title":"美迪西（688202）披露2025年年度股东会会议资料，5月8日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633543780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633543780?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:27","pubTimestamp":1778236037,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，美迪西报收于61.26元，较前一交易日下跌0.31%，最新总市值为82.3亿元。该股当日开盘61.62元，最高62.07元，最低60.2元，成交额达1.93亿元，换手率为2.35%。美迪西于近日披露《2025年年度股东会会议资料》。公告显示，公司2025年年度股东大会将于2026年5月14日召开，会议资料包含2025年度董事会工作报告、财务决算报告、利润分配预案、未来三年股东分红回报规划、续聘审计机构、董事及高管薪酬制度、向银行申请授信额度等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800035885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633947223","title":"股市必读：美迪西一季报 - 第一季度单季净利润同比增长207.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633947223","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633947223?lang=zh_cn&edition=full","pubTime":"2026-05-06 01:00","pubTimestamp":1778000439,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，美迪西报收于63.26元，下跌3.79%，换手率8.19%，成交量11.01万手，成交额7.13亿元。来自业绩披露要点：美迪西2026年一季度归母净利润同比增长207.35%，达1561.54万元。股本股东变化股东户数变动近日美迪西披露，截至2026年3月31日公司股东户数为1.35万户，较12月31日减少411.0户，减幅为2.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600000309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632649146","title":"每周股票复盘：美迪西（688202）Q1净利同比增207.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632649146","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632649146?lang=zh_cn&edition=full","pubTime":"2026-05-02 01:48","pubTimestamp":1777657694,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，美迪西报收于63.26元，较上周的69.3元下跌8.72%。本周，美迪西4月28日盘中最高价报72.88元。美迪西当前最新总市值84.99亿元，在医疗服务板块市值排名23/51，在两市A股市值排名2322/5200。业绩披露要点美迪西2026年一季报显示，一季度公司主营收入3.65亿元，同比上升36.52%；归母净利润1561.54万元，同比上升207.35%；扣非净利润1087.63万元，同比上升156.11%；负债率29.2%，投资收益141.09万元，财务费用542.64万元，毛利率26.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631688151","title":"美迪西连亏三年：毛利率修复缓慢，诉讼与资产减值阴影未散","url":"https://stock-news.laohu8.com/highlight/detail?id=2631688151","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631688151?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:30","pubTimestamp":1777534200,"startTime":"0","endTime":"0","summary":"尽管美迪西在2025年交出了一份营收增长、亏损收窄的“回暖”成绩单，但深挖财务数据与经营细节，这家CRO企业仍面临多重结构性挑战。连续三年亏损、毛利率远未恢复至历史水平、资产减值持续侵蚀利润，以及一桩金额高达1.5亿元的未决诉讼，均构成其未来发展的隐忧。 近三年来，美迪西年年计提资产减值。只要行业供需关系未恢复至平衡状态，美迪西的资产减值风险就难以完全消除。根据公司年报披露，该诉讼已立案但尚未开庭审理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-30/doc-inhwhkui1284691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631238540","title":"图解美迪西一季报：第一季度单季净利润同比增长207.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631238540","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631238540?lang=zh_cn&edition=full","pubTime":"2026-04-30 02:49","pubTimestamp":1777488587,"startTime":"0","endTime":"0","summary":"证券之星消息，美迪西2026年一季报显示，一季度公司主营收入3.65亿元，同比上升36.52%；归母净利润1561.54万元，同比上升207.35%；扣非净利润1087.63万元，同比上升156.11%；负债率29.2%，投资收益141.09万元，财务费用542.64万元，毛利率26.05%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000008124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630480704","title":"每周股票复盘：美迪西（688202）2025年营收增12.08%，股东户数降2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630480704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630480704?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:31","pubTimestamp":1777156262,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，美迪西报收于69.3元，较上周的69.45元下跌0.22%。本周，美迪西4月20日盘中最高价报72.66元。业绩披露要点：美迪西2025年主营收入11.63亿元，同比上升12.08%。公司公告汇总：美迪西2025年内部控制有效，无重大缺陷。股本股东变化股东户数变动截至2026年3月31日，美迪西股东户数为1.35万户，较2025年12月31日减少411户，减幅2.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629721881","title":"美迪西(688202)3月31日股东户数1.35万户，较上期减少2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629721881","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629721881?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:28","pubTimestamp":1776936539,"startTime":"0","endTime":"0","summary":"证券之星消息，近日美迪西披露，截至2026年3月31日公司股东户数为1.35万户，较12月31日减少411.0户，减幅为2.96%。在医疗服务行业个股中，美迪西股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.63万户。从股价来看，2025年12月31日至2026年3月31日，美迪西区间涨幅为10.64%，在此期间股东户数减少411.0户，减幅为2.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300048003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688202","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629883389","title":"美迪西2025年营收11.63亿元增12.08%，境外收入占比升至47.15%、经营性现金流转正","url":"https://stock-news.laohu8.com/highlight/detail?id=2629883389","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629883389?lang=zh_cn&edition=full","pubTime":"2026-04-23 15:38","pubTimestamp":1776929908,"startTime":"0","endTime":"0","summary":"数据显示，公司2025年实现营业收入11.63亿元，同比增长12.08%；归母净利润为-1.68亿元，亏损同比收窄49.27%；扣非净利润为-1.81亿元，亏损同比收窄47.90%。临床前研究业务收入为5.89亿元，占主营业务收入50.73%；药物发现与药学研究业务收入为5.73亿元，占主营业务收入49.27%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776922400864515692","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688202","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621776362","title":"3月23日美迪西跌5.85%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621776362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621776362?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:36","pubTimestamp":1774254976,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日美迪西跌5.85%创60日新低，收盘报52.0元，换手率2.41%，成交量3.23万手，成交额1.72亿元。重仓美迪西的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。信澳优享生活混合A目前规模为1.67亿元，最新净值1.029，较上一交易日下跌2.33%，近一年上涨14.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1597","01717","BK1237","BK1500","BK0216","688202","BK1553"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620843270","title":"【机构调研记录】长盛基金调研美迪西、万马科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2620843270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620843270?lang=zh_cn&edition=full","pubTime":"2026-03-20 08:01","pubTimestamp":1773964911,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及3月19日披露的机构调研信息，长盛基金近期对2家上市公司进行了调研，相关名单如下：1）美迪西 调研纪要：近期实验用猴市场价格呈上行趋势，公司已积极采取丰富采购渠道、深化与实验动物供应商的合作等多项措施保障供应稳定。2）万马科技 调研纪要：公司紧凑型一二次融合环网箱以干燥空气为绝缘介质，具备绿色环保、高可靠、智能化等优势，应用于多种电力场景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000005891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300698","688202","BK0214","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779949787712,"stockEarnings":[{"period":"1week","weight":-0.0397},{"period":"1month","weight":-0.1337},{"period":"3month","weight":-0.1144},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.9512},{"period":"ytd","weight":0.0777}],"compareEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0128},{"period":"6month","weight":0.0528},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0315}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海美迪西生物医药股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"13496人(较上一季度减少2.96%)","perCapita":"9954股","listingDate":"2019-11-05","address":"上海市浦东新区中国(上海)自由贸易试验区李冰路67弄5号楼","registeredCapital":"13435万元","survey":" 上海美迪西生物医药股份有限公司的主营业务是通过研发技术平台向药企及科研单位提供药物发现与药学研究、临床前研究的医药研发服务。公司的主要产品是药物发现、药学研究、临床前研究。2025年6月20日，公司凭借在生物医药领域的全球化研发布局，成功入选浦东新区首批“出海先锋企业”，全球化发展成果获得权威认可。","listedPrice":41.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美迪西(688202)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美迪西(688202)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美迪西,688202,美迪西股票,美迪西股票老虎,美迪西股票老虎国际,美迪西行情,美迪西股票行情,美迪西股价,美迪西股市,美迪西股票价格,美迪西股票交易,美迪西股票购买,美迪西股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美迪西(688202)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美迪西(688202)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}